AbbVie, J&J to add proprietary data to AI protein model in bid to accelerate drug discovery
Posted:
Life sciences data company Apheris on Thursday announced an effort to boost the capabilities of protein AI models by uniting several pharmaceutical companies’ proprietary data. Apheris’ consortium of pharma companies is partnering with OpenFold3 — Columbia professor Mohammed AlQuraishi’s open-source dupe of AlphaFold3 — to train the model on AbbVie and Johnson & Johnson’s vast stores of structural data. The collaboration will focus on structures relevant to drug discovery, such as small molecule-protein and antibody-antigen interactions.
The Swedish company Everdrone is launching a newly developed drone (E3) designed to enable both more frequent and faster deployments to emergency calls. The drone can also be equipped to carry both defibrillators and other emergency medical equipment.
Read more…
In the demanding environment of the NHS, asking staff to find extra time for exercise can feel like 1 more burden on an already stretched workforce – much like telling someone who’s burned out to simply be more resilient. Yet…